Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model
暂无分享,去创建一个
A. Nilsson | M. Willis | S. Traina | K. Kellerborg | R. Beale | I. Newell | P. Ball | R. Roe